Antibody-based Programme(DISCO Pharmaceuticals)

N/A

Report date: 2024/02/05 15:01:12

Base Information

Drug NameAntibody-based Programme(DISCO Pharmaceuticals)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSmall Cell Lung CarcinomaColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDisco Pharmaceuticals SA
China Registration ClassN/A

Develop Information

Active CompaniesDisco Pharmaceuticals SA
Inactive CompaniesN/A
Active IndicationsSmall Cell Lung CarcinomaColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A